Reducing Allergic Manifestations in Children with Cow's Milk Allergy: Current Research

Roberto Berni Canani, MD, PhD, chief of the Pediatric Allergy Program in the Department of Translational Medicine, University of Naples, Italy, presents data from a trial of infants with cow's milk allergy (CMA). In Dr. Canani's trial, allergic manifestations during a 36-month trial of extensively hydrolyzed formula, with or without Lactobacillus rhamnosus GG, were determined in infants who had developed CMA between 1-12 months of age. Dr. Canani's research has implications for the treatment of cow's milk intolerance, and long-term outcomes for children who develop CMA, since substitutive formulas can be used to treat these patients.

This course does not offer CE credit.

  • Roberto Berni Canani, MD, PhD

    Chief of the Pediatric Allergy Program
    Department of Translational Medicine
    University of Naples, Italy

Learning Objectives

  • Identify the long-term risks associated with cow's milk allergy early in life
  • Mediate allergic manifestations in infants by applying a probiotic nutritional strategy